Long-Term Behavioral Changes After Cessation of Chronic Antidepressant Treatment in Olfactory Bulbectomized Rats

• Published in: Biological psychiatry (1969) 2007-04, Vol.61 (8), p.990-995
• Main Authors: Breuer, Megan E, Groenink, Lucianne, Oosting, Ronald S, Westenberg, Herman G.M, Olivier, Berend
• Format: Article
• Language: English
• Subjects: Adult and adolescent clinical studies; Analysis of Variance; Animals; Antidepressive Agents - administration & dosage; Behavior, Animal - drug effects; Behavior, Animal - physiology; Biological and medical sciences; Cessation of treatment; Citalopram - administration & dosage; Depression; Depression - drug therapy; Depression - etiology; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; escitalopram; Exploratory Behavior - drug effects; imipramine; Imipramine - administration & dosage; Male; Medical sciences; Mood disorders; Neuropharmacology; Olfaction Disorders - complications; Olfaction Disorders - etiology; Olfaction Disorders - pathology; Olfactory Bulb - surgery; olfactory bulbectomy; open field; Pharmacology. Drug treatments; Psychiatry; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease); Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychopharmacology; Rats; Rats, Sprague-Dawley; Time Factors
• ISSN: 0006-3223; 1873-2402
• DOI: 10.1016/j.biopsych.2006.08.032

Background Olfactory bulbectomy (OBX) in rats causes several behavioral and neurochemical central nervous system changes, reminiscent of symptoms of human depression. Moreover, depression-like behavior after OBX can be reversed with antidepressant drugs. However, the lasting effects of these antidepressant drugs on behavior after cessation of treatment have never been studied. Methods Male rats received OBX or sham surgery. After recovery, animals received 14 consecutive daily doses of imipramine (20 mg/kg), escitalopram (5 and 10 mg/kg), or vehicle. Animals were tested in an open field after acute, sub-chronic, and chronic injections, as well as 1, 2, 6, and 10 weeks after cessation of treatment. Results The OBX-induced hyperactivity was normalized after sub-chronic administration of imipramine and escitalopram. Two weeks after treatment, activity of OBX animals was comparable to sham-treated animals, but after 6 weeks, OBX animals treated with both doses of escitalopram had returned to pre-treatment hyperactivity levels. The OBX animals treated with the high imipramine dose (20 mg/kg) retained activity levels comparable to sham-treated animals until 10 weeks after cessation of treatment. Conclusions Chronic but not acute administration of imipramine and escitalopram normalizes OBX-induced hyperactivity. This effect continues for up to 10 weeks after cessation of treatment in a dose dependant manner.